These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 22038492)

  • 1. Assessment of long-term efficacy and safety of metyrapone monotherapy in a patient with ACTH-independent macronodular adrenal hyperplasia.
    Yoshida M; Umeda H; Iwama S; Nakayama S; Miyata M; Ogawa K; Maeda H; Oiso Y
    Endocrine; 2012 Feb; 41(1):160-1. PubMed ID: 22038492
    [No Abstract]   [Full Text] [Related]  

  • 2. Rational, effective metyrapone treatment of ACTH-independent bilateral macronodular adrenocortical hyperplasia (AIMAH).
    Omori N; Nomura K; Omori K; Takano K; Obara T
    Endocr J; 2001 Dec; 48(6):665-9. PubMed ID: 11873864
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oxyphil metaplasia of adrenal cortex secondary to metyrapone therapy.
    Suvarna SK; Stephenson TJ
    Histopathology; 2001 Nov; 39(5):546-7. PubMed ID: 11737320
    [No Abstract]   [Full Text] [Related]  

  • 4. [Adrenostatic treatment of ACTH-dependent Cushing syndrome using metyrapone and aminoglutethimide].
    Reincke M; Allolio B; Jaursch-Hancke C; Kaulen D; Winkelmann W
    Dtsch Med Wochenschr; 1987 Oct; 112(40):1532-5. PubMed ID: 2820688
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Familial adrenocorticotropin-independent Cushing's syndrome with bilateral macronodular adrenal hyperplasia.
    Findlay JC; Sheeler LR; Engeland WC; Aron DC
    J Clin Endocrinol Metab; 1993 Jan; 76(1):189-91. PubMed ID: 8380604
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Case report: Beneficial effect of 11β-hydroxylase inhibitor in the management of an elderly patient with an androgen-producing inoperable adrenal tumor.
    Ozawa W; Sato K; Miyakoshi T; Nishio S; Yamazaki M; Suzuki S; Komatsu M
    Geriatr Gerontol Int; 2013 Apr; 13(2):509-11. PubMed ID: 23551351
    [No Abstract]   [Full Text] [Related]  

  • 7. Increased adrenal androgen secretion with inhibition of 11beta-hydroxylase in HIV-infected women.
    Koutkia P; Berry J; Eaton K; Breu J; Grinspoon S
    Am J Physiol Endocrinol Metab; 2006 May; 290(5):E808-13. PubMed ID: 16303845
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-term efficacy of trilostane for Cushing's syndrome due to adrenocorticotropin-independent bilateral macronodular adrenocortical hyperplasia.
    Obata Y; Yamada Y; Baden MY; Hosokawa Y; Saisho K; Tamba S; Yamamoto K; Matsuzawa Y
    Intern Med; 2011; 50(21):2621-5. PubMed ID: 22041369
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [ACTH-independent Cushing's syndrome due to bilateral macronodular adrenal hyperplasia with empty sella turcica and anterior panhypopituitarism].
    Menéndez Torre EL; López Carballo MT; Rodríguez Erdozain R; Urbieta Echezarreta M; Lafita Tejedor J; Forga Llenas L
    Rev Clin Esp; 1992 Mar; 190(5):261-3. PubMed ID: 1315980
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cushing's syndrome with dual pituitary-adrenal control.
    Choi Y; Werk EE; Sholiton LJ
    Arch Intern Med; 1970 Jun; 125(6):1045-9. PubMed ID: 4378134
    [No Abstract]   [Full Text] [Related]  

  • 11. Preclinical Cushing's disease characterized by massive adrenal hyperplasia and hormonal changes after three years of metyrapone therapy.
    Ohmori N; Nomura K; Ohmori K; Takano K
    Endocr J; 2007 Jun; 54(3):391-7. PubMed ID: 17446657
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Metyrapone in long-term management of Cushing's disease.
    Jeffcoate WJ; Rees LH; Tomlin S; Jones AE; Edwards CR; Besser GM
    Br Med J; 1977 Jul; 2(6081):215-7. PubMed ID: 195666
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Metyrapone for Cushing's syndrome.
    Inagaki M; Akizuki N; Kugaya A; Fujii H; Akechi T; Uchitomi Y
    Am J Psychiatry; 2002 Jul; 159(7):1246. PubMed ID: 12091216
    [No Abstract]   [Full Text] [Related]  

  • 14. Usefulness and limitations of unilateral adrenalectomy for ACTH-independent macronodular adrenal hyperplasia in a patient with poor glycemic control.
    Kobayashi T; Miwa T; Kan K; Takeda M; Sakai H; Kanazawa A; Tanaka A; Namiki K; Nagao T; Odawara M
    Intern Med; 2012; 51(13):1709-13. PubMed ID: 22790131
    [TBL] [Abstract][Full Text] [Related]  

  • 15. ACTH-independent bilateral macronodular adrenocortical hyperplasia caused Cushing's syndrome.
    Miyajima A; Nakashima J; Tachibana M; Baba S; Nakamura K; Murai M
    Urol Int; 1997; 58(4):259-61. PubMed ID: 9253133
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Alopecia associated with long-term metyrapone use.
    Harris PL
    Clin Pharm; 1986 Jan; 5(1):66-8. PubMed ID: 3004800
    [No Abstract]   [Full Text] [Related]  

  • 17. Is unilateral adrenalectomy an alternative treatment for ACTH-independent macronodular adrenal hyperplasia?: Long-term follow-up of four cases.
    Lamas C; Alfaro JJ; Lucas T; Lecumberri B; Barceló B; Estrada J
    Eur J Endocrinol; 2002 Feb; 146(2):237-40. PubMed ID: 11834434
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Improvement of hypercortisolism by β-blocker therapy in subclinical Cushing's syndrome associated with ACTH-independent macronodular adrenocortical hyperplasia.
    Oki K; Yamane K; Nakanishi S; Nakashima R; Jitsuiki K; Kohno N
    Endocrine; 2009 Dec; 36(3):372-6. PubMed ID: 19813002
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Macronodular adrenal hyperplasia in Cushing disease.
    Doppman JL; Miller DL; Dwyer AJ; Loughlin T; Nieman L; Cutler GB; Chrousos GP; Oldfield E; Loriaux DL
    Radiology; 1988 Feb; 166(2):347-52. PubMed ID: 2827231
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Cushing's syndrome due to bilateral adrenal macronodular hyperplasia. From ACTH-dependent hypercortisolism to ACTH-independent hypercortisolism].
    López JM; Sapunar J; Donoso J; Martínez P
    Rev Med Chil; 1991 Oct; 119(10):1165-70. PubMed ID: 1668993
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.